Literature DB >> 9677292

Recombination between subtypes creates a mosaic lineage of LINE-1 that is expressed and actively retrotransposing in the mouse genome.

J A Saxton1, S L Martin.   

Abstract

LINE-1, or L1, elements are retrotransposons that have amplified to high-copy number during the evolution of mammals. L1 appears to amplify in waves, spawning large numbers of progeny such that elements with distinct sequence features dominate the dispersal process in a given window of time. This process generates discrete subfamilies of L1 within mammalian genomes, with the oldest being remnants, or fossils, of earlier waves of amplification. In mice, at least three distinct subfamilies of L1 were distinguished by their unique 5' ends, A, F and V. These subfamilies amplified at distinct times in the evolution of mice, with A being the youngest and V the oldest; both V and F subfamilies were believed extinct. Recent data established that a variant of the F family, TF, is actively retrotransposing. We demonstrate here that members of the TF subfamily are abundantly expressed in mouse cells and encode the major protein constituent of L1 ribonucleoprotein particles. Although members of the TF subfamily are not as numerous in the genomes of laboratory mice as are members of the older A and F subfamilies, they appear to have been activated some time ago during mouse evolution, in the common ancestor of Mus spretus and Mus domesticus. Phylogenetic analysis demonstrates that this modern, active form of TF-type L1 has a composite evolutionary history, showing evidence of multiple recombinations between distinct L1 variants, including members of the A and F subfamilies. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9677292     DOI: 10.1006/jmbi.1998.1899

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  20 in total

1.  A double-strand break in a chromosomal LINE element can be repaired by gene conversion with various endogenous LINE elements in mouse cells.

Authors:  A Tremblay; M Jasin; P Chartrand
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  Nucleic acid chaperone activity of the ORF1 protein from the mouse LINE-1 retrotransposon.

Authors:  S L Martin; F D Bushman
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

3.  ATLAS: a system to selectively identify human-specific L1 insertions.

Authors:  Richard M Badge; Reid S Alisch; John V Moran
Journal:  Am J Hum Genet       Date:  2003-03-11       Impact factor: 11.025

4.  Molecular evolution and tempo of amplification of human LINE-1 retrotransposons since the origin of primates.

Authors:  Hameed Khan; Arian Smit; Stéphane Boissinot
Journal:  Genome Res       Date:  2005-12-12       Impact factor: 9.043

5.  Multiple fates of L1 retrotransposition intermediates in cultured human cells.

Authors:  Nicolas Gilbert; Sheila Lutz; Tammy A Morrish; John V Moran
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

6.  A novel active L1 retrotransposon subfamily in the mouse.

Authors:  J L Goodier; E M Ostertag; K Du; H H Kazazian
Journal:  Genome Res       Date:  2001-10       Impact factor: 9.043

7.  Characterization of in vivo recombination activities in the mouse embryo.

Authors:  Hugo Würtele; Nadine Gusew; Roxane Lussier; Pierre Chartrand
Journal:  Mol Genet Genomics       Date:  2005-04-14       Impact factor: 3.291

8.  Extensive variation between inbred mouse strains due to endogenous L1 retrotransposition.

Authors:  Keiko Akagi; Jingfeng Li; Robert M Stephens; Natalia Volfovsky; David E Symer
Journal:  Genome Res       Date:  2008-04-01       Impact factor: 9.043

9.  A YY1-binding site is required for accurate human LINE-1 transcription initiation.

Authors:  Jyoti N Athanikar; Richard M Badge; John V Moran
Journal:  Nucleic Acids Res       Date:  2004-07-22       Impact factor: 16.971

10.  Hypomethylation of L1 retrotransposons in colorectal cancer and adjacent normal tissue.

Authors:  Catherine M Suter; David I Martin; Robyn L Ward
Journal:  Int J Colorectal Dis       Date:  2003-10-08       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.